Molecular mapping of deletion sites in the short arm of chromosome 3 in human lung cancer

✍ Scribed by Dr. Hiltrud Brauch; Kalman Tory; Frederick Kotler; Adi F. Gazdar; Olive S. Pettengill; Bruce Johnson; Stephen Graziano; Tim Winton; Charles H. C. M. Buys; George D. Sorenson; Bernard J. Poiesz; John D. Minna; Berton Zbar

• Publisher: John Wiley and Sons
• Year: 1990
• Tongue: English
• Weight: 619 KB
• Volume: 1
• Category: Article
• ISSN: 1045-2257
• DOI: 10.1002/gcc.2870010309

✦ Synopsis

We used I0 restriction fragment length polymorphism (RFLP) probes spanning the length of the short arm of chromosome 3 (3p) t o map deletion sites in human lung cancer. Two approaches were used. I) When a patient's tumor and normal tissue were available, loci with allelic heterozygosity in the normal tissue were tested for loss of alleles at 3p. 2) When the corresponding normal tissue was not available, the frequency of heterozygosity at each locus in a panel of tumors was compared t o the corresponding published frequencies in nontumor tissue of healthy individuals or patients with lung cancer. In 14 small cell lung carcinomas (SCLC) with normal DNA for comparison, allele loss was found at all heterozygous loci, with one exception at a locus near the 3p centromere (D3S4). In the total of 53 SCLCs, which included tumors without paired normal tissue, frequency of heterozygosity was significantly reduced in all 10 3p loci. Three loci, DNF15S2, RAFI, and D3Sl8, were homozygous in all tumors in the SCLC panel. These loci, which are in regions 3p2 I and 3p25, may thus be involved in the origin or evolution of SCLC. We also investigated 24 non-SCLC tumors. In this panel, frequency of heterozygosity was significantly reduced at seven of the 10 loci tested. Comparison of the results shows that the pattern of allele loss on 3p is different in SCLC and non-SCLC, suggesting a difference in pathogenesis at the genetic level.